By Symeon Missios, MD — Long Island Brain & Spine

A woman in her early sixties comes into my office holding a folded MRI report. She is calm at the front desk but unspools by the time she sits down. Her primary care doctor ordered the scan after a few weeks of mild headaches. The headaches are gone now. But the report contains a line she cannot stop reading:

“Scattered T2/FLAIR hyperintensities in the periventricular and subcortical white matter, compatible with chronic microvascular ischemic change.”

She looks at me. “Doctor, what does this mean? Have I been having tiny strokes I didn’t know about?”

This conversation happens in my office several times a month. The wording on radiology reports has gotten more standardized — and more frightening — over the last decade, even as the imaging findings themselves have stayed almost entirely the same. Patients leave the lab with a piece of paper that uses words like ischemic, leukoaraiosis, small vessel disease, or demyelination — and they have, very reasonably, no way to know whether they should be terrified or relieved.

Here is the honest version of that conversation.

What “White Matter” Even Is

The brain has two main types of tissue. Gray matter contains the bodies of nerve cells — most of it sits at the surface of the brain and in deep structures like the thalamus and basal ganglia. White matter is the wiring: long fibers covered in myelin (a fatty insulating sheath) that connect gray matter regions to each other and to the spinal cord.

When you read an MRI report describing white matter, you are reading a description of the brain’s wiring, not its processing centers. White matter takes up about half the volume of the adult brain.

On most MRI sequences, healthy white matter looks darker than gray matter. On the FLAIR sequence — designed to suppress signal from cerebrospinal fluid — anything abnormal in the white matter tends to light up bright. Those bright spots are what radiologists describe with terms like hyperintensities, foci, lesions, or changes.

What “White Matter Hyperintensities” Mean on a Report

Almost every adult past middle age has at least a few of these spots. By age 60, the prevalence approaches 95% [1]. The radiology report typically uses one of several terms, often interchangeably:

• White matter hyperintensities (WMHs) — the most neutral, descriptive term
• Leukoaraiosis — literally “white matter rarefaction,” coined in the 1980s before we understood what it represented
• Small vessel ischemic disease / chronic microvascular ischemia — implying that small blood vessels in the deep brain have been working at reduced capacity over years
• Periventricular vs. subcortical — describing where in the white matter the spots are located

Most of the time, these are not strokes. They are not active. They are not, in isolation, a diagnosis. They are a visible record of the cumulative wear on the small blood vessels of the brain — the kind of damage that builds slowly across years from blood pressure, glucose control, cholesterol, and time.

The framework most useful for patients is this: white matter changes are the brain’s equivalent of the rust and wear that show up on the underside of an aging car. Their presence is a signal worth paying attention to. Their presence is not, by itself, an emergency.

Why They Show Up

The most common contributors, in roughly the order they matter, are:

• Age. The single strongest factor. The brain accumulates these changes in nearly everyone given enough time.
• Hypertension. Even mild, longstanding high blood pressure damages the small penetrating arteries of the brain. This is the largest modifiable contributor [2].
• Diabetes and insulin resistance. Damage small vessels throughout the body, brain included.
• Smoking, dyslipidemia, atrial fibrillation, sleep apnea. All contribute.
• Migraine with aura. Patients with longstanding migraine sometimes have small punctate white matter spots that have a different significance than vascular ones.
• Genetic small-vessel disease (rare). Conditions like CADASIL cause an exaggerated pattern of white matter changes, often starting in younger adulthood with family history.
• Multiple sclerosis and other inflammatory or demyelinating conditions. Produce a distinct pattern in different locations than vascular changes — usually obvious to a trained reader.

The pattern, distribution, and shape of the spots tell a trained reader most of what they need to know about which of these causes is in play.

When It’s Probably Nothing

A typical reassuring picture in a patient over 50 looks something like:

• A handful of small spots, mostly in the deep white matter
• Symmetric distribution
• No active enhancement after IV contrast
• No mass effect, no swelling, no surrounding edema
• The patient is neurologically normal
• The patient has the usual cardiovascular risk profile (some hypertension, normal labs, no concerning history)

A radiology report describing this picture in clinical terms can read as alarming — phrases like “chronic microvascular ischemic disease” sound dire — but the underlying finding is, in most patients, expected. Not desirable, not ignorable, but expected.

When It Might Be Something

A handful of features change the conversation. The presence of any of these is what would push me from reassurance to further workup:

• The patient is under 40 or 45. Significant white matter changes at that age are not normal aging.
• The lesions are large, confluent, or strikingly numerous for the patient’s age.
• The pattern is atypical — for example, prominent involvement of the corpus callosum, the cerebellar peduncles, or certain brainstem regions. These patterns suggest specific conditions (MS, CADASIL, certain inflammatory or genetic disorders) rather than ordinary vascular wear.
• There is associated symptomatology — clear cognitive decline, focal neurological symptoms, gait disturbance, prominent imbalance.
• The lesions enhance with contrast. Most chronic small-vessel changes do not. Active enhancement implies an active process — inflammation, infection, demyelination, or rarely, neoplasm.
• There is a strong family history of early stroke, dementia, or unexplained neurological disease.

In these cases, the right next step is usually a referral to neurology, sometimes a more detailed MRI with contrast and additional sequences, and occasionally blood work or lumbar puncture to look for underlying causes.

What I Actually Look For

When a patient hands me an MRI report describing white matter changes, the question I am answering is not really “do these spots exist?” — they almost certainly do — but “do these spots match what I would expect for this person, and are they doing anything to this person right now?”

Three things tell me almost everything:

• The patient’s age and cardiovascular profile. A 70-year-old with hypertension and the typical scattered spots is a different conversation from a 38-year-old non-smoker with the same picture.
• The neurological exam. A normal exam in a fully functional patient is a powerful piece of reassurance regardless of what the MRI shows.
• The images themselves, not just the report. Radiology reports are summaries written under time pressure. Looking at the actual scan often reveals that “scattered changes” means three small dots — or alternatively, that something more substantial was understated in the wording.

This is why bringing the actual MRI disc, not just the report, to a consultation matters.

What You Can Do About It

If the picture is one of typical age-related small vessel disease, the treatment is almost entirely about not letting it get worse. The same risk factors that drive these changes drive stroke and vascular dementia, and reducing them has been repeatedly shown to slow the progression of white matter changes on serial imaging [3].

The interventions worth doing, in approximate order of impact:

• Treat blood pressure to target. The single most powerful lever.
• Treat diabetes and prediabetes. Glycemic control matters at the level of small vessels.
• Stop smoking. No partial credit.
• Treat sleep apnea if present. It is more common — and more damaging — than most patients realize.
• Physical activity — the most consistent neuroprotective intervention we have, with the additional benefit of helping nearly every other risk factor on this list.
• Statin therapy when indicated by overall cardiovascular risk.
• Anticoagulation if atrial fibrillation is present.

None of these reverses changes that are already there. All of them slow the rate at which new changes accumulate. Given enough years of consistent application, the difference is large.

The Cousins: Other Common Incidental Findings

White matter changes are the most common incidental finding on brain MRI, but they are not the only one. Patients who go through a workup like this often end up reading similar uncertainty-laden language about a small unruptured aneurysm or a small meningioma or other slow-growing brain lesion. The framework is the same in each case: most of the time, the right answer is informed surveillance and risk-factor modification, not intervention. Some of the time, it is more than that. Knowing which conversation you are in requires both the imaging and the clinical context — see also my piece on aneurysms and vascular disorders for the parallel conversation in the cerebrovascular space.

The Bottom Line

A radiology report mentioning white matter changes, hyperintensities, or chronic microvascular disease is not a diagnosis of having had silent strokes, and it is not a reason for panic. For most adults past middle age, the finding is expected — a visible record of cumulative cardiovascular wear. For most patients, the right response is not a new prescription or a procedure but a careful look at blood pressure, glucose, sleep, activity, and the rest of the cardiovascular picture.

For a minority of patients — those who are younger, those whose pattern is atypical, those with neurological symptoms, those with family history — the same finding is the opening of a different conversation. The challenge is knowing which conversation you are in. That is what the visit is for.

If you have an MRI report you do not fully understand and would like a careful, in-person review of both the images and your overall risk picture, our offices in West Islip and Smithtown are here to help. Bring the disc, not just the report.

Dr. Symeon Missios is a board-certified neurosurgeon practicing on Long Island, with expertise in brain and spine surgery, cerebrovascular disease, and stereotactic radiosurgery. To schedule a consultation or second opinion, request an appointment or call (631) 422-5371 or toll-free (888) 737-5427.

 

References

1. de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. J Neurol Neurosurg Psychiatry. 2001;70(1):9–14. doi:10.1136/jnnp.70.1.9
2. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12(5):483–497. doi:10.1016/S1474-4422(13)70060-7
3. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666. doi:10.1136/bmj.c3666